A method for increasing antibody-dependent cytotoxicity with castanospermine

Details for Australian Patent Application No. 2007308983 (hide)

Owner Trubion Pharmaceuticals, Inc.

Inventors Espling, Erik Stephen; Thompson, Peter Armstrong; Baum, Peter Robert

Agent Peter Maxwell & Associates

Pub. Number AU-A-2007308983

PCT Pub. Number WO2008/052030

Priority 60/853,944 24.10.06 US

Filing date 24 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/052030 Priority application(s): WO2008/052030

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007308986-Ibuprofen composition

2007308982-Synthetic shingle or tile with stress relief nail zones